IL-13 can also bind to IL-13Rα2 on tumor cells and enhance tumor invasion and metastasis through activating ERK/activator protein 1 (AP-1) signaling and matrix metalloproteinases (Hallett et al., 2012). The gene discussed is MAPK1; the disease is neoplasm.